Figure 5.
The combined treatment of hydralazine and enzalutamide induced an increase in the amount of 7AAD in PCa (prostate cancer) cells. Values were normalized to the vehicle condition (A). Corresponding histograms depicting the amount of 7AAD (B). (MFI—mean fluorescence intensity, V—vehicle, H—hydralazine, E—enzalutamide, H+E—combination of hydralazine and enzalutamide).